These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

707 related articles for article (PubMed ID: 26876179)

  • 1. MCT1 Modulates Cancer Cell Pyruvate Export and Growth of Tumors that Co-express MCT1 and MCT4.
    Hong CS; Graham NA; Gu W; Espindola Camacho C; Mah V; Maresh EL; Alavi M; Bagryanova L; Krotee PAL; Gardner BK; Behbahan IS; Horvath S; Chia D; Mellinghoff IK; Hurvitz SA; Dubinett SM; Critchlow SE; Kurdistani SK; Goodglick L; Braas D; Graeber TG; Christofk HR
    Cell Rep; 2016 Feb; 14(7):1590-1601. PubMed ID: 26876179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD147 subunit of lactate/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors.
    Le Floch R; Chiche J; Marchiq I; Naiken T; Ilc K; Murray CM; Critchlow SE; Roux D; Simon MP; Pouysségur J
    Proc Natl Acad Sci U S A; 2011 Oct; 108(40):16663-8. PubMed ID: 21930917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of the monocarboxylate transporter 1 inhibitor AZD3965 in small cell lung cancer.
    Polański R; Hodgkinson CL; Fusi A; Nonaka D; Priest L; Kelly P; Trapani F; Bishop PW; White A; Critchlow SE; Smith PD; Blackhall F; Dive C; Morrow CJ
    Clin Cancer Res; 2014 Feb; 20(4):926-937. PubMed ID: 24277449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of BASIGIN decreases lactic acid export and sensitizes non-small cell lung cancer to biguanides independently of the LKB1 status.
    Granja S; Marchiq I; Le Floch R; Moura CS; Baltazar F; Pouysségur J
    Oncotarget; 2015 Mar; 6(9):6708-21. PubMed ID: 25894929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical Efficacy of the Novel Monocarboxylate Transporter 1 Inhibitor BAY-8002 and Associated Markers of Resistance.
    Quanz M; Bender E; Kopitz C; Grünewald S; Schlicker A; Schwede W; Eheim A; Toschi L; Neuhaus R; Richter C; Toedling J; Merz C; Lesche R; Kamburov A; Siebeneicher H; Bauser M; Hägebarth A
    Mol Cancer Ther; 2018 Nov; 17(11):2285-2296. PubMed ID: 30115664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MCT4 as a potential therapeutic target for metastatic gastric cancer with peritoneal carcinomatosis.
    Lee JY; Lee I; Chang WJ; Ahn SM; Lim SH; Kim HS; Yoo KH; Jung KS; Song HN; Cho JH; Kim SY; Kim KM; Lee S; Kim ST; Park SH; Lee J; Park JO; Park YS; Lim HY; Kang WK
    Oncotarget; 2016 Jul; 7(28):43492-43503. PubMed ID: 27224918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer.
    Curry JM; Tuluc M; Whitaker-Menezes D; Ames JA; Anantharaman A; Butera A; Leiby B; Cognetti DM; Sotgia F; Lisanti MP; Martinez-Outschoorn UE
    Cell Cycle; 2013 May; 12(9):1371-84. PubMed ID: 23574725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD147 regulates the expression of MCT1 and lactate export in multiple myeloma cells.
    Walters DK; Arendt BK; Jelinek DF
    Cell Cycle; 2013 Oct; 12(19):3175-83. PubMed ID: 24013424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vitro and In Vivo Efficacy of AZD3965 and Alpha-Cyano-4-Hydroxycinnamic Acid in the Murine 4T1 Breast Tumor Model.
    Guan X; Morris ME
    AAPS J; 2020 Jun; 22(4):84. PubMed ID: 32529599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression.
    Sanità P; Capulli M; Teti A; Galatioto GP; Vicentini C; Chiarugi P; Bologna M; Angelucci A
    BMC Cancer; 2014 Mar; 14():154. PubMed ID: 24597899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting metabolic activity in high-risk neuroblastoma through Monocarboxylate Transporter 1 (MCT1) inhibition.
    Khan A; Valli E; Lam H; Scott DA; Murray J; Hanssen KM; Eden G; Gamble LD; Pandher R; Flemming CL; Allan S; Osterman AL; Haber M; Norris MD; Fletcher JI; Yu DMT
    Oncogene; 2020 Apr; 39(17):3555-3570. PubMed ID: 32123312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear factor E2-related factor-2 has a differential impact on MCT1 and MCT4 lactate carrier expression in colonic epithelial cells: a condition favoring metabolic symbiosis between colorectal cancer and stromal cells.
    Diehl K; Dinges LA; Helm O; Ammar N; Plundrich D; Arlt A; Röcken C; Sebens S; Schäfer H
    Oncogene; 2018 Jan; 37(1):39-51. PubMed ID: 28846107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monocarboxylate Transporters MCT1 and MCT4 Regulate Migration and Invasion of Pancreatic Ductal Adenocarcinoma Cells.
    Kong SC; Nøhr-Nielsen A; Zeeberg K; Reshkin SJ; Hoffmann EK; Novak I; Pedersen SF
    Pancreas; 2016 Aug; 45(7):1036-47. PubMed ID: 26765963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hodgkin lymphoma: A complex metabolic ecosystem with glycolytic reprogramming of the tumor microenvironment.
    Mikkilineni L; Whitaker-Menezes D; Domingo-Vidal M; Sprandio J; Avena P; Cotzia P; Dulau-Florea A; Gong J; Uppal G; Zhan T; Leiby B; Lin Z; Pro B; Sotgia F; Lisanti MP; Martinez-Outschoorn U
    Semin Oncol; 2017 Jun; 44(3):218-225. PubMed ID: 29248133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking lactate export by inhibiting the Myc target MCT1 Disables glycolysis and glutathione synthesis.
    Doherty JR; Yang C; Scott KE; Cameron MD; Fallahi M; Li W; Hall MA; Amelio AL; Mishra JK; Li F; Tortosa M; Genau HM; Rounbehler RJ; Lu Y; Dang CV; Kumar KG; Butler AA; Bannister TD; Hooper AT; Unsal-Kacmaz K; Roush WR; Cleveland JL
    Cancer Res; 2014 Feb; 74(3):908-20. PubMed ID: 24285728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic disruption of lactate/H+ symporters (MCTs) and their subunit CD147/BASIGIN sensitizes glycolytic tumor cells to phenformin.
    Marchiq I; Le Floch R; Roux D; Simon MP; Pouyssegur J
    Cancer Res; 2015 Jan; 75(1):171-80. PubMed ID: 25403912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of metabolism-related biomarkers in non-Hodgkin lymphoma - MCT1 as potential target in diffuse large B cell lymphoma.
    Afonso J; Pinto T; Simões-Sousa S; Schmitt F; Longatto-Filho A; Pinheiro C; Marques H; Baltazar F
    Cell Oncol (Dordr); 2019 Jun; 42(3):303-318. PubMed ID: 30790227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of monocarboxylate transporter-1 (MCT1) by AZD3965 enhances radiosensitivity by reducing lactate transport.
    Bola BM; Chadwick AL; Michopoulos F; Blount KG; Telfer BA; Williams KJ; Smith PD; Critchlow SE; Stratford IJ
    Mol Cancer Ther; 2014 Dec; 13(12):2805-16. PubMed ID: 25281618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interruption of lactate uptake by inhibiting mitochondrial pyruvate transport unravels direct antitumor and radiosensitizing effects.
    Corbet C; Bastien E; Draoui N; Doix B; Mignion L; Jordan BF; Marchand A; Vanherck JC; Chaltin P; Schakman O; Becker HM; Riant O; Feron O
    Nat Commun; 2018 Mar; 9(1):1208. PubMed ID: 29572438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exercise-induced changes in tumour LDH-B and MCT1 expression are modulated by oestrogen-related receptor alpha in breast cancer-bearing BALB/c mice.
    Aveseh M; Nikooie R; Aminaie M
    J Physiol; 2015 Jun; 593(12):2635-48. PubMed ID: 25907793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.